Premium
Development of the “Inje Cocktail” for High‐throughput Evaluation of Five Human Cytochrome P450 Isoforms in vivo
Author(s) -
Ryu J Y,
Song I S,
Sunwoo Y E,
Shon J H,
Liu K H,
Cha I J,
Shin J G
Publication year - 2007
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.6100187
Subject(s) - in vivo , cytochrome p450 , gene isoform , throughput , pharmacology , chemistry , computational biology , medicine , computer science , biology , biochemistry , microbiology and biotechnology , enzyme , gene , telecommunications , wireless
To develop and validate an in vivo cocktail method for high‐throughput phenotyping of CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A, 12 healthy subjects received five probe drugs alone or simultaneously. The in vivo phenotyping index of CYP2C9, the ratio of 8 h urine concentration of losartan to its metabolite after a single administration of losartan, was not significantly different from that obtained using the five‐drug cocktail. Similarly, the ratios of [omeprazole]/[5‐hydroxyomeprazole] (CYP2C19) and [paraxanthine]/[caffeine] (CYP1A2) in 4 h plasma samples and the log ratio of [dextromethorphan]/[dextrorphan] (CYP2D6) in 8 h urine samples and the 4 h plasma concentrations of midazolam (CYP3A) after single administration or well‐established three‐drug cocktail of caffeine, omeprazole, and dextromethorphan were not significantly different from those after the new five‐drug cocktail. In conclusion, the new five‐drug cocktail regimen, named the “Inje cocktail,” can be used as a tool to phenotype in vivo enzyme activities of CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A with only 4 h blood sampling and 8 h urine collection following simultaneous administration of the five probe drugs. Clinical Pharmacology & Therapeutics (2007) 82 , 531–540; doi: 10.1038/sj.clpt.6100187 ; published online 28 March 2007